Awakn Life Sciences Corp.

CNSX:AWKN Stock Report

Market Cap: CA$4.0m

Awakn Life Sciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Anthony Tennyson

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.6yrs
CEO ownership4.9%
Management average tenureno data
Board average tenure3.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Anthony Tennyson's remuneration changed compared to Awakn Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Oct 31 2024n/an/a

-CA$3m

Jul 31 2024n/an/a

-CA$3m

Apr 30 2024n/an/a

-CA$4m

Jan 31 2024n/an/a

-CA$4m

Oct 31 2023n/an/a

-CA$3m

Jul 31 2023n/an/a

-CA$3m

Apr 30 2023n/an/a

-CA$3m

Jan 31 2023CA$311kCA$240k

-CA$5m

Oct 31 2022n/an/a

-CA$8m

Jul 31 2022n/an/a

-CA$10m

Apr 30 2022n/an/a

-CA$18m

Jan 31 2022CA$348kCA$220k

-CA$16m

Oct 31 2021n/an/a

-CA$13m

Jan 31 2021CA$72kCA$52k

-CA$1m

Compensation vs Market: Insufficient data to establish whether Anthony's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Anthony's compensation has been consistent with company performance over the past year.

CEO

Anthony Tennyson

4.6yrs

Tenure

CA$311,400

Compensation

Mr. Anthony Tennyson is a Co-founder and has been President & Chief Executive Officer of Awakn Life Sciences Corp. since June 1, 2020 and has been its Director since May 21, 2020. Mr. Tennyson serves as Ex...

Board Members

NamePositionTenureCompensationOwnership
George Scorsis
Co-founder & Chairman of the Board4.7yrsCA$34.26k2.71%
CA$ 107.4k
Anthony Tennyson
Co-founder4.7yrsCA$311.40k4.85%
CA$ 192.2k
David Nutt
Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer3.6yrsno data0.34%
CA$ 13.3k
Barbara Mason
Member of Clinical Advisory Board3.5yrsno datano data
Paul Rutherford Carter
Independent Director3.1yrsCA$48.85kno data
Shaun McNulty
Member of Pre-Clinical Advisory Board3.5yrsCA$241.21kno data
Stephen Page
Independent Non Executive Director3.8yrsCA$18.76k0.16%
CA$ 6.5k
John Papastergiou
Independent Non Executive Director3.8yrsCA$18.76k0.094%
CA$ 3.7k
Kevin Fone
Member of Pre-Clinical Advisory Board3.5yrsno datano data
Harriet de Wit
Member of Pre-Clinical Advisory Board3.5yrsno datano data
Stephen Husbands
Member of Pre-Clinical Advisory Board3.5yrsno datano data

3.5yrs

Average Tenure

Experienced Board: AWKN's board of directors are considered experienced (3.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 01:38
End of Day Share Price 2024/12/13 00:00
Earnings2024/10/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Awakn Life Sciences Corp. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Patrick TrucchioH.C. Wainwright & Co.
Andrew PartheniouStifel Canada